Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to fall 5.78% to -21 cents per share on August 03

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.16

Q2'25

Beat

by $0.13

The last earnings report on May 11 showed earnings per share of -23 cents, missing the estimate of -21 cents. With 19.99K shares outstanding, the current market capitalization sits at 32.32M.

View a ticker or compare two or three

Compare

ATNM

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ATNM